TYLENOL

Product NDC
50580-412
11-digit product format
505800412
Labeler code
50580
Product ID
50580-412_e292b337-630b-6302-e053-2a95a90a33c2
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division
Application
part343
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2016-09-19
Marketing end
0000-00-00
Substance
ACETAMINOPHEN
Active strength
500 mg/1
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct50580-412DDiscontinued by firm2026-11-16
excluded packagepackage50580-41250580-412-01DDiscontinued by firm2026-11-16
excluded packagepackage50580-41250580-412-02DDiscontinued by firm2026-11-16
excluded packagepackage50580-41250580-412-03DDiscontinued by firm2026-11-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductIInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50580-412-02DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50580-412-01IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage50580-412-03IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductIInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50580-412-02DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50580-412-01IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage50580-412-03IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage50580-412-02DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage50580-412-02DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage50580-412-02DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage50580-412-02DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage50580-412-02DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage50580-412-02DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage50580-412-02DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage50580-412-02DDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage50580-412-02DDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage50580-412-02DDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50580-412-012025-07-29C16284748780-13b156c62-2fc7-fb37-e063-e6dba90a4e07TYLENOL ® Extra Strength
50580-412-022025-07-29C16284748780-13b156c62-2fc7-fb37-e063-e6dba90a4e07TYLENOL ® Extra Strength
50580-412-032025-07-29C16284748780-13b156c62-2fc7-fb37-e063-e6dba90a4e07TYLENOL ® Extra Strength

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50580-412-01EA - Each50580-412e83ba222-51f7-4a19-b370-2cc7622b9fb412016-11-08
50580-412-02EA - Each50580-412dcf82923-528a-499a-9639-9d8f1395140912016-12-07
50580-412-03EA - Each50580-41284199ea6-face-4e7f-a00f-02b512d0702412016-11-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50580-412TYLENOL EXTRA STRENGTH (ACETAMINOPHEN) TABLET, FILM COATED [KENVUE BRANDS LLC]8Legacy NDC20241109_24477946-63ed-456b-97e8-9d487f365cfa.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50580-412-0150580041201100 TABLET, FILM COATED in 1 BOTTLE (50580-412-01) 2016-09-190000-00-00NoNoCurrent
50580-412-025058004120210 BLISTER PACK in 1 CARTON (50580-412-02) > 10 TABLET, FILM COATED in 1 BLISTER PACK10 blister pack2016-09-190000-00-00NoNoCurrent
50580-412-0350580041203700 TABLET, FILM COATED in 1 BOTTLE (50580-412-03) 2016-09-190000-00-00NoNoCurrent